Vaccine trains immune system to fight HPV-Positive head and neck tumors
Disease control
Recruiting now
This trial tests a vaccine called BVAC-E6E7 in people with head and neck cancer linked to HPV types 16 or 18 that cannot be removed by surgery or has spread. The vaccine is designed to teach the immune system to attack cancer cells. The study first checks safety and the best dose…
Phase: PHASE1, PHASE2 • Sponsor: Cellid Co., Ltd. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC